// App-Quantinova.ai

: Factors associated with access to treatment for pancreatic cancer in New Zealand

Researchers

Presenter

  • J. Oo

Principal Investigators

  • I. Nielsen

  • B. Van der Werf

  • S. Pandanaboyana

  • B. Loveday

Medical Centers

  • University of Auckland, New Zealand.

  • Royal Melbourne Hospital, Australia

  • Department of HPB and Transplant Surgery, Freeman Hospital, United Kingdom

  • Peter MacCallum Cancer Center, Sydney, Australia

  • University of Gothenburg, Sweden

Locations

  • New Zealand

  • Australia

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreato-biliary malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Thymidylate synthase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved